Vaxxilon AG today announced that Arne von Bonin, PhD has been appointed to the role of Chief Scientific Officer (CSO). Dr. von Bonin is responsible for preclinical and early phase development for Vaxxilon’s multiple projects including the design, implementation and execution of proof of concept and toxicology studies, Phase 1/2 trials and associated regulatory filings.

BASEL OFFICE

Vaxxilon AG
Christoph Merian-Ring 11
4153 Reinach Switzerland

BERLIN OFFICE

Vaxxilon Deutschland GmbH
Magnusstraße 11
12489 Berlin, Germany